Genmab
Associate Director, Global Market Access & Pricing – Solid Tumors at Genmab will lead launch readiness activities and help develop and execute global access and pricing strategies for an oncology asset targeting solid tumors. The role is a key contributor on the global market access and pricing team, working closely with cross-functional colleagues, regional/country partners, and external vendors to support bringing the medicine to patients. This position is hybrid-based in Princeton, NJ and reports to the Director, Global Access & Pricing.
Headquarters
Valby, Hovedstaden, Denmark
Company Size
1001-5000 employees
Founded
1999
Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genmab.
Genmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
3 days ago
Director Global Market Access & Pricing, frexalimab
Sanofi
Director, Global Market Access
ionis
Director, Global Market Access
ionis
Director; Global Value, Access & Pricing; Solid Tumors, Pipeline
BeOne Medicines
Associate Director, Market Access & Pricing
BeOne Medicines
Director, Global Market Access, Immunology
MSD